Shenzhen Fosun Kairos Biotechnology Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Shenzhen Fosun Kairos Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy (NCT07765537) | Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 2026-08-01 |
| A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis (NCT07765524) | Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 2026-08-01 |
| A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma. (NCT07606937) | Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 2026-06-12 |
Track Shenzhen Fosun Kairos Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.